 |
인쇄하기
취소
|
Testing of newly modified Korean anticancer drug approved by U.S. FDA
SK Chemicals Co., Ltd. said on August 11 it has received approval from the U.S. Food and Drug Administration to conduct advanced clinical trial of a drug for the treatment of cancer.
During the year 2008, the company developed newly modified anticancer drug 'SID530' (docetaxel) by its Life Science Research Center.
“Once all of the clinical trials have been completed without complications,...
During the year 2008, the company developed newly modified anticancer drug 'SID530' (docetaxel) by its Life Science Research Center.
“Once all of the clinical trials have been completed without complications,...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.